nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—Function kidney decreased—Metformin—metabolic syndrome X	0.113	0.128	CcSEcCtD
Levetiracetam—Toothache—Metformin—metabolic syndrome X	0.0405	0.0458	CcSEcCtD
Levetiracetam—Fungal infection—Metformin—metabolic syndrome X	0.0319	0.0361	CcSEcCtD
Levetiracetam—Rhinorrhoea—Metformin—metabolic syndrome X	0.0304	0.0344	CcSEcCtD
Levetiracetam—Blood disorder—Metformin—metabolic syndrome X	0.0295	0.0333	CcSEcCtD
Levetiracetam—Contusion—Metformin—metabolic syndrome X	0.0283	0.0319	CcSEcCtD
Levetiracetam—Accidental injury—Metformin—metabolic syndrome X	0.0279	0.0315	CcSEcCtD
Levetiracetam—Ear pain—Metformin—metabolic syndrome X	0.021	0.0237	CcSEcCtD
Levetiracetam—Nasal congestion—Metformin—metabolic syndrome X	0.0196	0.0222	CcSEcCtD
Levetiracetam—Injury—Metformin—metabolic syndrome X	0.0195	0.022	CcSEcCtD
Levetiracetam—Renal impairment—Metformin—metabolic syndrome X	0.0188	0.0212	CcSEcCtD
Levetiracetam—Lethargy—Metformin—metabolic syndrome X	0.0183	0.0206	CcSEcCtD
Levetiracetam—Dehydration—Metformin—metabolic syndrome X	0.0166	0.0188	CcSEcCtD
Levetiracetam—Liver function test abnormal—Metformin—metabolic syndrome X	0.0165	0.0187	CcSEcCtD
Levetiracetam—Abdominal pain upper—Metformin—metabolic syndrome X	0.0163	0.0185	CcSEcCtD
Levetiracetam—Nasopharyngitis—Metformin—metabolic syndrome X	0.016	0.0181	CcSEcCtD
Levetiracetam—Influenza—Metformin—metabolic syndrome X	0.0155	0.0175	CcSEcCtD
Levetiracetam—Pancreatitis—Metformin—metabolic syndrome X	0.0152	0.0171	CcSEcCtD
Levetiracetam—Neutropenia—Metformin—metabolic syndrome X	0.0145	0.0163	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.0144	0.0162	CcSEcCtD
Levetiracetam—Infestation NOS—Metformin—metabolic syndrome X	0.0138	0.0156	CcSEcCtD
Levetiracetam—Infestation—Metformin—metabolic syndrome X	0.0138	0.0156	CcSEcCtD
Levetiracetam—Drowsiness—Metformin—metabolic syndrome X	0.0138	0.0156	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Metformin—metabolic syndrome X	0.013	0.0147	CcSEcCtD
Levetiracetam—Rhinitis—Metformin—metabolic syndrome X	0.0124	0.014	CcSEcCtD
Levetiracetam—Hepatitis—Metformin—metabolic syndrome X	0.0124	0.014	CcSEcCtD
Levetiracetam—Connective tissue disorder—Metformin—metabolic syndrome X	0.0122	0.0137	CcSEcCtD
Levetiracetam—Eye disorder—Metformin—metabolic syndrome X	0.0116	0.0131	CcSEcCtD
Levetiracetam—Immune system disorder—Metformin—metabolic syndrome X	0.0112	0.0126	CcSEcCtD
Levetiracetam—Mediastinal disorder—Metformin—metabolic syndrome X	0.0112	0.0126	CcSEcCtD
Levetiracetam—Malnutrition—Metformin—metabolic syndrome X	0.0108	0.0122	CcSEcCtD
Levetiracetam—Vision blurred—Metformin—metabolic syndrome X	0.0102	0.0115	CcSEcCtD
Levetiracetam—Tremor—Metformin—metabolic syndrome X	0.0101	0.0114	CcSEcCtD
Levetiracetam—ABCC2—Drug Induction of Bile Acid Pathway—NR1I3—metabolic syndrome X	0.00963	0.0839	CbGpPWpGaD
Levetiracetam—Myalgia—Metformin—metabolic syndrome X	0.00918	0.0104	CcSEcCtD
Levetiracetam—Chest pain—Metformin—metabolic syndrome X	0.00918	0.0104	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00911	0.0103	CcSEcCtD
Levetiracetam—ABCC2—Drug Induction of Bile Acid Pathway—NR1I2—metabolic syndrome X	0.00881	0.0767	CbGpPWpGaD
Levetiracetam—Infection—Metformin—metabolic syndrome X	0.00874	0.00987	CcSEcCtD
Levetiracetam—Nervous system disorder—Metformin—metabolic syndrome X	0.00863	0.00974	CcSEcCtD
Levetiracetam—Thrombocytopenia—Metformin—metabolic syndrome X	0.00861	0.00973	CcSEcCtD
Levetiracetam—Skin disorder—Metformin—metabolic syndrome X	0.00854	0.00965	CcSEcCtD
Levetiracetam—Anorexia—Metformin—metabolic syndrome X	0.00838	0.00947	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00801	0.00905	CcSEcCtD
Levetiracetam—Paraesthesia—Metformin—metabolic syndrome X	0.0079	0.00892	CcSEcCtD
Levetiracetam—Somnolence—Metformin—metabolic syndrome X	0.00782	0.00883	CcSEcCtD
Levetiracetam—Dyspepsia—Metformin—metabolic syndrome X	0.00774	0.00875	CcSEcCtD
Levetiracetam—Decreased appetite—Metformin—metabolic syndrome X	0.00765	0.00864	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.00759	0.00858	CcSEcCtD
Levetiracetam—Fatigue—Metformin—metabolic syndrome X	0.00758	0.00857	CcSEcCtD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H3—metabolic syndrome X	0.00756	0.0658	CbGpPWpGaD
Levetiracetam—Constipation—Metformin—metabolic syndrome X	0.00752	0.0085	CcSEcCtD
Levetiracetam—Feeling abnormal—Metformin—metabolic syndrome X	0.00725	0.00819	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00719	0.00812	CcSEcCtD
Levetiracetam—Abdominal pain—Metformin—metabolic syndrome X	0.00695	0.00785	CcSEcCtD
Levetiracetam—Asthenia—Metformin—metabolic syndrome X	0.00631	0.00713	CcSEcCtD
Levetiracetam—Pruritus—Metformin—metabolic syndrome X	0.00622	0.00703	CcSEcCtD
Levetiracetam—Diarrhoea—Metformin—metabolic syndrome X	0.00602	0.0068	CcSEcCtD
Levetiracetam—Dizziness—Metformin—metabolic syndrome X	0.00582	0.00657	CcSEcCtD
Levetiracetam—ABCC2—Constitutive Androstane Receptor Pathway—NR1I3—metabolic syndrome X	0.00581	0.0506	CbGpPWpGaD
Levetiracetam—Vomiting—Metformin—metabolic syndrome X	0.00559	0.00632	CcSEcCtD
Levetiracetam—Rash—Metformin—metabolic syndrome X	0.00555	0.00626	CcSEcCtD
Levetiracetam—Dermatitis—Metformin—metabolic syndrome X	0.00554	0.00626	CcSEcCtD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—metabolic syndrome X	0.00553	0.0482	CbGpPWpGaD
Levetiracetam—Headache—Metformin—metabolic syndrome X	0.00551	0.00622	CcSEcCtD
Levetiracetam—Nausea—Metformin—metabolic syndrome X	0.00522	0.0059	CcSEcCtD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—metabolic syndrome X	0.00506	0.0441	CbGpPWpGaD
Levetiracetam—ABCB1—Drug Induction of Bile Acid Pathway—NR1I3—metabolic syndrome X	0.00453	0.0395	CbGpPWpGaD
Levetiracetam—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—metabolic syndrome X	0.00414	0.0361	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H3—metabolic syndrome X	0.00355	0.031	CbGpPWpGaD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.00291	0.0253	CbGpPWpGaD
Levetiracetam—ABCB1—Constitutive Androstane Receptor Pathway—NR1I3—metabolic syndrome X	0.00273	0.0238	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—metabolic syndrome X	0.0026	0.0227	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—metabolic syndrome X	0.00238	0.0207	CbGpPWpGaD
Levetiracetam—SV2A—Disease—G6PC2—metabolic syndrome X	0.00231	0.0201	CbGpPWpGaD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.00201	0.0175	CbGpPWpGaD
Levetiracetam—ABCC2—ABC-family proteins mediated transport—APOA1—metabolic syndrome X	0.0018	0.0157	CbGpPWpGaD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.00166	0.0145	CbGpPWpGaD
Levetiracetam—SV2A—Disease—G6PD—metabolic syndrome X	0.00166	0.0145	CbGpPWpGaD
Levetiracetam—SV2A—Disease—HDAC3—metabolic syndrome X	0.00162	0.0141	CbGpPWpGaD
Levetiracetam—SV2A—Disease—GCKR—metabolic syndrome X	0.00158	0.0138	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—G6PD—metabolic syndrome X	0.00154	0.0134	CbGpPWpGaD
Levetiracetam—SV2A—Disease—TRIB3—metabolic syndrome X	0.00141	0.0123	CbGpPWpGaD
Levetiracetam—SV2A—Disease—RBP4—metabolic syndrome X	0.00141	0.0123	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.00137	0.0119	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NAMPT—metabolic syndrome X	0.00127	0.011	CbGpPWpGaD
Levetiracetam—SV2A—Disease—GCK—metabolic syndrome X	0.00126	0.011	CbGpPWpGaD
Levetiracetam—SV2A—Disease—APOC3—metabolic syndrome X	0.00125	0.0109	CbGpPWpGaD
Levetiracetam—SV2A—Disease—HMGA1—metabolic syndrome X	0.00115	0.01	CbGpPWpGaD
Levetiracetam—SV2A—Disease—GOT2—metabolic syndrome X	0.0011	0.00956	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CYBA—metabolic syndrome X	0.00109	0.00952	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—GCK—metabolic syndrome X	0.00103	0.009	CbGpPWpGaD
Levetiracetam—SV2A—Disease—SLC2A4—metabolic syndrome X	0.000978	0.00852	CbGpPWpGaD
Levetiracetam—SV2A—Disease—GOT1—metabolic syndrome X	0.000948	0.00826	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.000947	0.00825	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—SLC2A4—metabolic syndrome X	0.000906	0.00789	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—GGT1—metabolic syndrome X	0.000877	0.00764	CbGpPWpGaD
Levetiracetam—ABCB1—ABC-family proteins mediated transport—APOA1—metabolic syndrome X	0.000849	0.00739	CbGpPWpGaD
Levetiracetam—SV2A—Disease—APOB—metabolic syndrome X	0.000804	0.00701	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.000783	0.00682	CbGpPWpGaD
Levetiracetam—SV2A—Disease—LPL—metabolic syndrome X	0.000768	0.00669	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—G6PC2—metabolic syndrome X	0.000685	0.00597	CbGpPWpGaD
Levetiracetam—SV2A—Disease—APOE—metabolic syndrome X	0.000644	0.00561	CbGpPWpGaD
Levetiracetam—SV2A—Disease—APOA1—metabolic syndrome X	0.000636	0.00554	CbGpPWpGaD
Levetiracetam—SV2A—Disease—IRS1—metabolic syndrome X	0.000574	0.005	CbGpPWpGaD
Levetiracetam—SV2A—Disease—INS—metabolic syndrome X	0.00055	0.00479	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—LEP—metabolic syndrome X	0.000529	0.00461	CbGpPWpGaD
Levetiracetam—SV2A—Disease—SERPINE1—metabolic syndrome X	0.000505	0.0044	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NOS3—metabolic syndrome X	0.000482	0.0042	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	0.000469	0.00409	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PTGS2—metabolic syndrome X	0.000441	0.00384	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—metabolic syndrome X	0.000415	0.00361	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—GCK—metabolic syndrome X	0.000373	0.00325	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—CETP—metabolic syndrome X	0.00036	0.00314	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—G6PC2—metabolic syndrome X	0.000322	0.00281	CbGpPWpGaD
Levetiracetam—SV2A—Disease—TGFB1—metabolic syndrome X	0.000319	0.00278	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—TGFB1—metabolic syndrome X	0.000295	0.00257	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	0.00029	0.00253	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—metabolic syndrome X	0.000286	0.0025	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—metabolic syndrome X	0.000275	0.00239	CbGpPWpGaD
Levetiracetam—SV2A—Disease—IL6—metabolic syndrome X	0.00024	0.00209	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—APOB—metabolic syndrome X	0.000238	0.00208	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—TGFB1—metabolic syndrome X	0.000227	0.00198	CbGpPWpGaD
Levetiracetam—SV2A—Disease—AKT1—metabolic syndrome X	0.000222	0.00193	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	0.000221	0.00192	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—TNF—metabolic syndrome X	0.000212	0.00185	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	0.000201	0.00175	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	0.000189	0.00164	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—metabolic syndrome X	0.000187	0.00163	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—AKT1—metabolic syndrome X	0.000182	0.00159	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—FMO3—metabolic syndrome X	0.00018	0.00157	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—GCK—metabolic syndrome X	0.000175	0.00153	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—CETP—metabolic syndrome X	0.000169	0.00147	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—EPHX2—metabolic syndrome X	0.00016	0.0014	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—MLXIPL—metabolic syndrome X	0.00016	0.0014	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—metabolic syndrome X	0.000155	0.00135	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—G6PC2—metabolic syndrome X	0.000151	0.00131	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ALB—metabolic syndrome X	0.000149	0.0013	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	0.000136	0.00119	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—FABP4—metabolic syndrome X	0.000128	0.00112	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HSD11B1—metabolic syndrome X	0.000122	0.00106	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	0.000112	0.000976	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	0.000112	0.000975	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—G6PD—metabolic syndrome X	0.000108	0.000944	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HDAC3—metabolic syndrome X	0.000106	0.000922	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	0.000105	0.000911	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—LPA—metabolic syndrome X	0.000103	0.000901	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GCKR—metabolic syndrome X	0.000103	0.000901	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PLA2G6—metabolic syndrome X	0.0001	0.000872	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—APOA5—metabolic syndrome X	9.91e-05	0.000864	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	9.45e-05	0.000824	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—TRIB3—metabolic syndrome X	9.22e-05	0.000803	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	8.87e-05	0.000773	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NAMPT—metabolic syndrome X	8.27e-05	0.00072	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GCK—metabolic syndrome X	8.21e-05	0.000716	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—LIPC—metabolic syndrome X	8.21e-05	0.000716	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—APOC3—metabolic syndrome X	8.16e-05	0.000711	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CETP—metabolic syndrome X	7.92e-05	0.00069	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	7.78e-05	0.000678	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SCARB1—metabolic syndrome X	7.59e-05	0.000661	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SREBF1—metabolic syndrome X	7.37e-05	0.000642	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HMGCR—metabolic syndrome X	7.17e-05	0.000624	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GOT2—metabolic syndrome X	7.17e-05	0.000624	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	7.03e-05	0.000612	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ABCA1—metabolic syndrome X	6.39e-05	0.000557	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	6.39e-05	0.000557	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GGT1—metabolic syndrome X	6.19e-05	0.000539	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GOT1—metabolic syndrome X	6.19e-05	0.000539	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—APOB—metabolic syndrome X	5.25e-05	0.000457	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	5.11e-05	0.000445	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—LPL—metabolic syndrome X	5.01e-05	0.000437	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CD36—metabolic syndrome X	4.76e-05	0.000415	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PPARA—metabolic syndrome X	4.43e-05	0.000386	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—AGT—metabolic syndrome X	4.29e-05	0.000374	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—APOE—metabolic syndrome X	4.2e-05	0.000366	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—APOA1—metabolic syndrome X	4.15e-05	0.000362	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PPARG—metabolic syndrome X	3.66e-05	0.000319	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—INS—metabolic syndrome X	3.59e-05	0.000313	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ALB—metabolic syndrome X	3.29e-05	0.000287	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NOS3—metabolic syndrome X	3.15e-05	0.000274	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PTGS2—metabolic syndrome X	2.88e-05	0.000251	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—AKT1—metabolic syndrome X	1.45e-05	0.000126	CbGpPWpGaD
